Injectafer (ferric carboxymaltose) is a prescription drug that’s used to treat iron deficiency anemia. Injectafer comes as a liquid solution for intravenous (IV) injection or infusion. It’s always ...
BASKING RIDGE, N.J. and SHIRLEY, N.Y., May 6, 2021 /PRNewswire/ -- Daiichi Sankyo, Inc. and American Regent, Inc., a Daiichi Sankyo Group company, today announced that the U.S. Food and Drug ...
Injectafer (ferric carboxymaltose) is a brand-name liquid solution prescribed for iron deficiency anemia (IDA) in certain adults and children ages 1 year and older. It’s unknown whether Injectafer is ...
As with other drugs, Injectafer (ferric carboxymaltose) can cause side effects, such as nausea, high blood pressure, and flushed skin. If the side effects of Injectafer become difficult to tolerate, ...
First and only high-dose intravenous iron for iron deficiency anemia of various etiologies SHIRLEY, N.Y.--(BUSINESS WIRE)--American Regent, Inc., a subsidiary of Luitpold Pharmaceuticals, Inc. (a ...
Injectafer® approved in the U.S. for the treatment of iron deficiency in patients with heart failure
Injectafer ® (ferric carboxymaltose) is now the first and only intravenous (i.v.) iron replacement therapy in the U.S. indicated for improvement in exercise capacity in adult patients with symptomatic ...
Credit: Getty Images. Injectafer is an iron replacement product. The Food and Drug Administration (FDA) has expanded the approval of Injectafer ® (ferric carboxymaltose injection) to include patients ...
BASKING RIDGE, N.J. and SHIRLEY, N.Y., May 6, 2021 /PRNewswire/ — Daiichi Sankyo, Inc. and American Regent, Inc., a Daiichi Sankyo Group company, today announced that the U.S. Food and Drug ...
BASKING RIDGE, N.J. and SHIRLEY, N.Y., May 6, 2021 /PRNewswire/ — Daiichi Sankyo, Inc. and American Regent, Inc., a Daiichi Sankyo Group company, today announced that the U.S. Food and Drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback